Lesofavumab
Lesofavumab (MHAB5553A) is a human IgG1κ anti-influenza B virus antibody[1].
Product Specifications
CAS Number
1807960-57-1
Product Name Alternative
MHAB5553A; RG70026
UNSPSC
12352203
Target
Influenza Virus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lesofavumab.html
Purity
98.27
Solubility
H2O
Smiles
[Lesofavumab]
Molecular Weight
(147.08 kDa)
References & Citations
[1]Rao GK, et al. In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection. Toxicol Sci. 2019 Jun 1;169 (2) :409-421.|[2]Chai N, et al. A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action. Nat Commun. 2017 Jan 19;8:14234.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
L2020-73N-FITC 200 µL
Leucine Rich Repeat and Ig Domain Containing 1, NT (Leucine-rich Repeat and Immunoglobulin-like Domain-containing Nogo Receptor-interacting Protein 1, Lingo 1, LINGO1, Lingo-1, FLJ14594, Leucine-rich Repeat and Immunoglobilin Domain-containing Protein 1, Leucine-rich Repeat Neuronal Protein 1, LERN1, Leucine-rich Repeat Neuronal Protein 6A, LRRN6A, MGC17422, UNQ201/PRO227) (FITC) discontinued
Sign In for Pricing
View Details MBS9366786-01 48 Well
Hamster Phosphatidate Cytidylyltransferase 2 (PCDS2) ELISA Kit
Sign In for Pricing
View Details